(Total Views: 440)
Posted On: 02/15/2021 2:23:17 PM
Post# of 154859
Quote:
Yes, I do think we'll be selling 10b worth of leronlimab in 2051.
For COVID? Again, my point is that we cannot apply a multiple to an indication that will be short lived. We may be able to make an argument for ARDS, if we prove it out.
And, once we have HIV approval, Cancer, Nash, etc.
(0)
(0)
